Draft User Fee Bills Aim To Streamline And Strengthen Device Regs
This article was originally published in The Gray Sheet
Executive Summary
Details on draft legislation circulating in the House and Senate.
You may also be interested in...
Congress Enters Final Stages On FDA Reform Bill
Legislative leaders say they remain on track to send FDA user fee reauthorization and reform legislation for the president’s signature by the end of June following House passage of bill.
Senate Plans FDA User Fee Markup This Week; House Not Far Behind
Updated draft user fee reauthorization bills issued last week reflect works in progress as lawmakers aim to reach consensus on FDA reforms.
Patient, Consumer Groups Decry Lack Of User Fee Funding For Post-Market Surveillance
Non-industry stakeholders criticized the medical device user fee agreement for not giving FDA enough funding, particularly to enhance post-market surveillance programs, during an FDA public meeting on user fee reauthorization.